We’re still figuring out the side effects of GLP-1 weight-loss drugs
AI Executive Summary
Gemini Analysis
This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs. According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age. Overweight and diabetic people who take GLP-1s have a biological age around two to three years younger than similar…
AI-generated summary based on publicly available article information. Original reporting and copyright belong to MIT Technology Review AI.
Explore the Complete Reporting
Read the original, unabridged story published directly on MIT Technology Review AI.